Cementos Bio (Chile) Performance
| CEMENTOS | CLP 1,400 100.00 7.69% |
Cementos Bio holds a performance score of 16 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.044, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cementos Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cementos Bio is expected to be smaller as well. Use Cementos Bio total risk alpha, as well as the relationship between the daily balance of power and price action indicator , to analyze future returns on Cementos Bio.
Risk-Adjusted Performance
16 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Cementos Bio B are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Cementos Bio displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 40.5 B | |
| Total Cashflows From Investing Activities | 5.3 B |
Cementos |
Cementos Bio Relative Risk vs. Return Landscape
If you would invest 68,200 in Cementos Bio B on August 30, 2024 and sell it today you would earn a total of 71,800 from holding Cementos Bio B or generate 105.28% return on investment over 90 days. Cementos Bio B is generating 3.4402% of daily returns and assumes 16.3084% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Cementos on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Cementos Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cementos Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cementos Bio B, and traders can use it to determine the average amount a Cementos Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2109
| Best Portfolio | Best Equity | |||
| Good Returns | CEMENTOS | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.31 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.44 actual daily | 68 68% of assets have lower returns |
Risk-Adjusted Return
| 0.21 actual daily | 16 84% of assets perform better |
Based on monthly moving average Cementos Bio is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cementos Bio by adding it to a well-diversified portfolio.
Cementos Bio Fundamentals Growth
Cementos Stock prices reflect investors' perceptions of the future prospects and financial health of Cementos Bio, and Cementos Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cementos Stock performance.
| Return On Equity | 0.0705 | |||
| Return On Asset | 0.0042 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 293.1 B | |||
| Shares Outstanding | 264.22 M | |||
| Price To Earning | 13.82 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 0.53 X | |||
| Revenue | 289.47 B | |||
| EBITDA | 38.71 B | |||
| Cash And Equivalents | 31.62 B | |||
| Cash Per Share | 119.65 X | |||
| Total Debt | 97.47 B | |||
| Debt To Equity | 55.80 % | |||
| Book Value Per Share | 910.74 X | |||
| Cash Flow From Operations | 25.84 B | |||
| Earnings Per Share | 65.73 X | |||
| Total Asset | 488.87 B | |||
About Cementos Bio Performance
By examining Cementos Bio's fundamental ratios, stakeholders can obtain critical insights into Cementos Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cementos Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Cementos Bio Bio S.A. manufactures and sells cement in Chile and internationally. The company was founded in 1957 and is based in Providencia, Chile. CEMENTOS BIO is traded on Commodity Exchange in Exotistan.Things to note about Cementos Bio B performance evaluation
Checking the ongoing alerts about Cementos Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cementos Bio B help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cementos Bio B is way too risky over 90 days horizon | |
| Cementos Bio B appears to be risky and price may revert if volatility continues | |
| About 82.0% of the company shares are held by company insiders |
- Analyzing Cementos Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cementos Bio's stock is overvalued or undervalued compared to its peers.
- Examining Cementos Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cementos Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cementos Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cementos Bio's stock. These opinions can provide insight into Cementos Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Cementos Stock
Cementos Bio financial ratios help investors to determine whether Cementos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cementos with respect to the benefits of owning Cementos Bio security.